Medical physics · 2025
Feasibility study of microwave-induced thermoacoustic/ultrasound dual-modality imaging for the assessment of nonalcoholic fatty liver disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Song Jieni, Ling Wenwu, Peng Wanting, Song Ling, Yang Zeqi, Feng Lian, Huang Lin, Luo Yan
Аннотация
BACKGROUND: Accurate and non-invasive diagnosis of nonalcoholic fatty liver disease (NAFLD) remains a critical challenge. Current methods are often costly, invasive, or lack sensitivity in early stages.
PURPOSE: To investigate the feasibility and accuracy of microwave-induced thermoacoustic/ultrasound (TAI/US) dual-modality imaging for the assessment of hepatic steatosis.
METHODS: A microwave-induced TAI/US dual-modality imaging system with a microwave source at a center frequency of 3 GHz as an excitation source was applied to image rabbit NAFLD models, and the spleen-to-liver thermoacoustic amplitude ratio (TARS-L) parameter was introduced to assess hepatic steatosis. Pathology was used as the gold standard, and Oil Red O staining fat fraction (ORO-FF) was calculated by a semi-quantitative software. Group differences in TARS-L across hepatic steatosis grades were assessed using the Kruskal-Wallis test with Dunn-Bonferroni post hoc comparisons. The Mann-Whitney U test and Cliff's Delta (δ) were applied to compare dichotomized steatosis subgroups. Spearman's rank correlation coefficient was used to evaluate the association between TARS-L and ORO-FF. Receiver Operating Characteristic (ROC) curve was performed to assess the diagnostic performance of TARS-L, and the results were quantified by the Area Under the Curve (AUC). A p < 0.05 was considered significant.
RESULTS: The results demonstrated that the thermoacoustic and ultrasound images from the microwave-induced TAI/US dual-modality imaging system could be well-fused. The median TARS-L values for normal (S0), mild (S1), moderate (S2), and severe (S3) steatosis were 1.110 (0.953-1.283), 1.260 (1.073-1.430), 1.740 (1.625-1.870), and 2.195 (1.833-2.580). TARS-L values increased with steatosis severity, showing a strong positive correlation with ORO-FF (r = 0.908, p < 0.001). Statistically significant differences with large effect sizes were observed in TARS-L between S0 vs. S3 and S1 vs. S3 (p < 0.05, |Cliff's δ| > 0.474), indicating marked group differences. While comparisons such as S0 vs. S2 and S1 vs. S2 lacked statistical significance (p > 0.05), large effect sizes (|Cliff's δ| > 0.474) suggest potential true differences limited by sample size. ROC analysis confirmed diagnostic performance, with AUC of 0.894 (0.764-1.000), 0.979 (0.931-1.000), and 0.953 (0.874-1.000) for distinguishing S0 vs. ≥S1, ≤S1 vs. ≥S2, and ≤S2 vs. S3, respectively.
CONCLUSION: At present, the diagnosis of NAFLD based on TAI still belongs to the research gap. Our study initially verified the potential of microwave-induced TAI/US dual-modality imaging combined with the thermoacoustic parameter TARS-L for the diagnosis of NAFLD. These findings establish a crucial methodological foundation for subsequent in-depth investigations into the application of microwave-induced TAI/US dual-modality imaging in the quantitative diagnosis of hepatic steatosis.
PURPOSE: To investigate the feasibility and accuracy of microwave-induced thermoacoustic/ultrasound (TAI/US) dual-modality imaging for the assessment of hepatic steatosis.
METHODS: A microwave-induced TAI/US dual-modality imaging system with a microwave source at a center frequency of 3 GHz as an excitation source was applied to image rabbit NAFLD models, and the spleen-to-liver thermoacoustic amplitude ratio (TARS-L) parameter was introduced to assess hepatic steatosis. Pathology was used as the gold standard, and Oil Red O staining fat fraction (ORO-FF) was calculated by a semi-quantitative software. Group differences in TARS-L across hepatic steatosis grades were assessed using the Kruskal-Wallis test with Dunn-Bonferroni post hoc comparisons. The Mann-Whitney U test and Cliff's Delta (δ) were applied to compare dichotomized steatosis subgroups. Spearman's rank correlation coefficient was used to evaluate the association between TARS-L and ORO-FF. Receiver Operating Characteristic (ROC) curve was performed to assess the diagnostic performance of TARS-L, and the results were quantified by the Area Under the Curve (AUC). A p < 0.05 was considered significant.
RESULTS: The results demonstrated that the thermoacoustic and ultrasound images from the microwave-induced TAI/US dual-modality imaging system could be well-fused. The median TARS-L values for normal (S0), mild (S1), moderate (S2), and severe (S3) steatosis were 1.110 (0.953-1.283), 1.260 (1.073-1.430), 1.740 (1.625-1.870), and 2.195 (1.833-2.580). TARS-L values increased with steatosis severity, showing a strong positive correlation with ORO-FF (r = 0.908, p < 0.001). Statistically significant differences with large effect sizes were observed in TARS-L between S0 vs. S3 and S1 vs. S3 (p < 0.05, |Cliff's δ| > 0.474), indicating marked group differences. While comparisons such as S0 vs. S2 and S1 vs. S2 lacked statistical significance (p > 0.05), large effect sizes (|Cliff's δ| > 0.474) suggest potential true differences limited by sample size. ROC analysis confirmed diagnostic performance, with AUC of 0.894 (0.764-1.000), 0.979 (0.931-1.000), and 0.953 (0.874-1.000) for distinguishing S0 vs. ≥S1, ≤S1 vs. ≥S2, and ≤S2 vs. S3, respectively.
CONCLUSION: At present, the diagnosis of NAFLD based on TAI still belongs to the research gap. Our study initially verified the potential of microwave-induced TAI/US dual-modality imaging combined with the thermoacoustic parameter TARS-L for the diagnosis of NAFLD. These findings establish a crucial methodological foundation for subsequent in-depth investigations into the application of microwave-induced TAI/US dual-modality imaging in the quantitative diagnosis of hepatic steatosis.